iNtRON Biotechnology, Inc. (048530) Price & Analysis

― Followers

048530 Stock Chart & Stats

$2415.00

-$30.00(-1.23%)

Jul 28, 2026

―

Day’s Range― - ―

52-Week Range$2,275.00 - $7,010.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩69.75B

Enterprise Value$102.20K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.17

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-72.53

Shares Outstanding30,891,758

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

048530 FAQ

What was iNtRON Biotechnology, Inc.’s price range in the past 12 months?

iNtRON Biotechnology, Inc. lowest stock price was $2275.00 and its highest was $7010.00 in the past 12 months.

What is iNtRON Biotechnology, Inc.’s market cap?

iNtRON Biotechnology, Inc.’s market cap is ₩69.75B.

When is iNtRON Biotechnology, Inc.’s upcoming earnings report date?

iNtRON Biotechnology, Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 106 days.

How were iNtRON Biotechnology, Inc.’s earnings last quarter?

iNtRON Biotechnology, Inc. released its earnings results on May 14, 2026. The company reported -$72.526 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is iNtRON Biotechnology, Inc. overvalued?

According to Wall Street analysts iNtRON Biotechnology, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does iNtRON Biotechnology, Inc. pay dividends?

iNtRON Biotechnology, Inc. does not currently pay dividends.

What is iNtRON Biotechnology, Inc.’s EPS estimate?

iNtRON Biotechnology, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does iNtRON Biotechnology, Inc. have?

iNtRON Biotechnology, Inc. has 30,891,758 shares outstanding.

What happened to iNtRON Biotechnology, Inc.’s price movement after its last earnings report?

iNtRON Biotechnology, Inc. reported an EPS of -$72.526 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.153%.

Which hedge fund is a major shareholder of iNtRON Biotechnology, Inc.?

Currently, no hedge funds are holding shares in KR:048530

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology